Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Pleiotropic Functions of Cytochrome P450 Monooxygenase-Derived Eicosanoids in Cancer.Frontiers in pharmacology · 2020
   Review
2. Thioalbamide, A Thioamidated Peptide fromCells · 2019
   Article
3. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.Nature reviews. Endocrinology · 2019
   Review
4. Metformin Affects Heme Function as a Possible Mechanism of Action.G3 (Bethesda, Md.) · 2019
   Article
5. Transcriptional Repression of CYP3A4 by Increased miR-200a-3p and miR-150-5p Promotes SteatosisFrontiers in genetics · 2019
   Article

Corrections and comments

• Erratum for
  Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.2017

Authors and funding

37 authors.

Funding

Abstract

PubMed holds no abstract for this paper.